Page 29 - Read Online
P. 29

Oiseth et al.                                                                                                                                                                                               Cancer immunotherapy

           112.  Jerne NK. The natural-selection theory of antibody formation. Proc   Natl Acad Sci U S A 1976;73:3628-32.
               Natl Acad Sci U S A 1955;41:849-57.            129. Quesada JR, Reuben J, Manning JT, Hersh EM, Gutterman JU. Alpha
           113.  Billingham, R E, Brent, L, Medawar, PB. Quantitative studies on tissue   interferon for induction of remission in hairy-cell leukemia. N Engl J
               transplantation immunity. III. Actively acquired tolerance. Available   Med 1984;310:15-8.
               from:  http://adsabs.harvard.edu/abs/1956RSPTB.239..357B.  [Last   130. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue
               accessed on 30 Oct 2017]                          of the Drosophila Toll protein signals activation of adaptive immunity.
           114.  Silverstein AM. The curious case of the 1960 Nobel Prize to Burnet   Nature 1997;388:394-7.
               and Medawar. Immunology 2016;147:269-74.       131. Poltorak  A, He X, Smirnova  I, Liu  MY,  Van Huffel C, Du X,
           115.  Prehn  RT,  Main  JM. Immunity  to  methylcholanthrene-induced   Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-
               sarcomas. J Natl Cancer Inst 1957;18:769-78.      Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/
           116.  Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R   HeJ  and C57BL/10ScCr mice: mutations in  Tlr4 gene.  Science
               Soc Lond B Biol Sci 1957;147:258-67.              1998;282:2085-8.
           117.  Porter RR. The hydrolysis of rabbit y-globulin and antibodies with   132. Shankaran  V, Ikeda H,  Bruce  AT,  White JM,  Swanson  PE, Old
               crystalline papain. Biochem J 1959;73:119-26.     LJ, Schreiber  RD. IFNgamma and lymphocytes  prevent  primary
           118.  Edelman GM, Poulik MD. Studies on structural units of the gamma-  tumour development and shape tumour immunogenicity.  Nature
               globulins. J Exp Med 1961;113:861-84.             2001;410:1107-11.
           119.  Fleischman JB, Porter RR, Press EM. The arrangement of the peptide   133. Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R,
               chains in gamma-globulin. Biochem J 1963;88:220-8.  Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval
           120. Edelman GM, Cunningham BA, Gall WE, Gottlieb PD, Rutishauser   P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J. Effector memory
               U,  Waxdal MJ.  The covalent  structure of an entire  gamma G   T cells, early metastasis, and survival in colorectal cancer. N Engl J
               immunoglobulin molecule. Proc Natl Acad Sci U S A 1969;63:78-85.  Med 2005;353:2654-66.
           121. Steinman  RM,  Cohn  ZA.  Identification  of  a  novel  cell  type  in   134. National Cancer Institute. FDA approval for Sipuleucel-T. Available
               peripheral  lymphoid organs of mice.  I. Morphology, quantitation,   from:  https://www.cancer.gov/about-cancer/treatment/drugs/fda-
               tissue distribution. J Exp Med 1973;137:1142-62.  sipuleucel-T. [Last accessed on 30 Oct 2017]
           122. Zinkernagel  RM,  Doherty PC.  Immunological  surveillance  against   135. Qasim W, Zhan H, Samarasinghe S, Adams S, Amrolia P, Stafford
               altered self components by sensitised T lymphocytes in lymphocytic   S, Butler K, Rivat C, Wright G, Somaa K, Ghorashian S, Pinner D,
               choriomeningitis. Nature 1974;251:547-8.          Ahsan G, Gilmour K, Lucchini G, Inglott S, Mifsud W, Chiesa R,
           123. Zinkernagel RM, Doherty PC. Restriction of in vitro T cell-mediated   Peggs KS, Chan L, Farzaneh F, Thrasher AJ, Vora A, Pule M, Veys
               cytotoxicity in lymphocytic choriomeningitis within a syngeneic or   P. Molecular remission of infant B-ALL after infusion of universal
               semiallogeneic system. Nature 1974;248:701-2.     TALEN gene-edited CAR T cells. Sci Transl Med 2017;9:eaaj2013.
           124. Köhler G, Milstein C. Continuous cultures of fused cells secreting   136. Mansh M. Ipilimumab and cancer immunotherapy: a new hope for
               antibody of predefined specificity. Nature 1975;256:495-7.  advanced stage melanoma. Yale J Biol Med 2011;84:381-9.
           125. Jerne NK.  The somatic  generation  of immune  recognition.  Eur J   137. U.S. Food and Drug Administration. Pembrolizumab (KEYTRUDA)
               Immunol 1971;1:1-9.                               Checkpoint  Inhibitor.  Available  from:  https://www.fda.gov/Drugs/
           126. Herberman  RB, Nunn ME, Holden  HT, Lavrin  DH. Natural   InformationOnDrugs/ApprovedDrugs/ucm526430.htm.  [Last
               cytotoxic reactivity of mouse lymphoid cells against syngeneic and   accessed on 30 Oct 2017]
               allogeneic tumors. II. Characterization of effector cells. Int J Cancer   138. Halpert MM, Konduri V, Liang D, Chen Y, Wing JB, Paust S, Levitt
               1975;16:230-9.                                    JM, Decker  WK. Dendritic  cell-secreted cytotoxic  T-lymphocyte-
           127. Tonegawa S. Reiteration  frequency of immunoglobulin  light  chain   associated protein-4 regulates the T-cell response by downmodulating
               genes: further evidence for somatic generation of antibody diversity.   bystander surface B7. Stem Cells Dev 2016;25:774-87.
               Proc Natl Acad Sci U S A 1976;73:203-7.        139. U.S. Food and Drug  Administration.  Atezolizumab  (Tecentriq).
           128. Hozumi  N,  Tonegawa S. Evidence  for somatic  rearrangement  of   Available  from:  https://www.fda.gov/drugs/informationondrugs/
               immunoglobulin genes coding for variable and constant regions. Proc   approveddrugs/ucm525780.htm. [Last accessed on 30 Oct 2017]



























                           Journal of Cancer Metastasis and Treatment ¦ Volume 3 ¦ October 31, 2017       261
   24   25   26   27   28   29   30   31   32   33   34